4//SEC Filing
HAUSMAN DIANA 4
Accession 0001725160-24-000111
CIK 0001725160other
Filed
May 8, 8:00 PM ET
Accepted
May 9, 7:46 PM ET
Size
355.2 KB
Accession
0001725160-24-000111
Insider Transaction Report
Form 4
HAUSMAN DIANA
Director
Transactions
- Sale
Common Stock
2024-05-09$12.62/sh−3,356$42,353→ 373,876 total
Footnotes (1)
- [F1]This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person.
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001563992
Filing Metadata
- Form type
- 4
- Filed
- May 8, 8:00 PM ET
- Accepted
- May 9, 7:46 PM ET
- Size
- 355.2 KB